UK anti-trust regulator investigates South Africa’s Aspen Pharmacare

JOHANNESBURG (Reuters) – Britain’s competition regulator has launched an investigation into Africa’s biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply